Business Wire

Endace and Artiza Networks Partner to Deliver Cybersecurity and Defense Solutions to the Japanese Market

8.7.2026 13:00:00 CEST | Business Wire | Press Release

Share

Endace, a leading provider of always-on packet capture, network visibility, and packet forensics solutions, and Artiza Networks, Inc. ("Artiza"), a leading provider of telecommunications test, measurement, and network assurance solutions, today announced a partnership to deliver advanced cybersecurity and defense solutions to customers in Japan.

“Artiza is exactly the partner we have been looking for to satisfy demand in Japan, with the right balance of expertise, and market reach,” said Stuart Wilson, CEO of Endace.

Through this partnership, Artiza will offer Endace's packet capture, network recording, and packet forensics solutions to customers in Japan, including telecommunications operators, enterprises, government agencies, defense organizations, and critical infrastructure providers.

Endace's EndaceProbe Analytics Platform provides highly scalable, always-on packet capture and recording capabilities across a wide range of network environments, including enterprise networks, data centers, telecommunications networks, on-premises infrastructures, hybrid cloud environments, and public cloud deployments. The platform enables Security Operations Center (SOC) and Network Operations Center (NOC) teams to investigate cybersecurity incidents, network performance issues, and operational anomalies by providing access to complete packet-level evidence.

Endace solutions integrate with a broad range of cybersecurity and network monitoring platforms, providing direct access to definitive packet evidence required for incident investigation, threat hunting, and root-cause analysis.

By making complete packet-level evidence available to security and operations teams, Endace helps organizations improve the effectiveness of cybersecurity investigations and network performance analysis.

In addition, Endace solutions have achieved important security certifications and approvals, including NIST FIPS 140-3 validation, Common Criteria / NIAP certification, and inclusion on the U.S. Department of Defense Information Network Approved Products List (DoDIN APL). These achievements demonstrate compliance with some of the world's most demanding cybersecurity requirements for government, defense, and critical infrastructure environments.

By combining Endace's advanced packet visibility and packet forensics technologies with Artiza's strong presence in the Japanese telecommunications and technology markets, the two companies will work together to support organizations seeking enhanced cybersecurity, operational resilience, and network assurance capabilities.

About Endace

Endace’s scalable, always-on packet capture gives Network Operations and Security teams the deep visibility they need for fast, accurate incident investigation with rich forensic evidence at their fingertips from all their tools. EndaceProbes provide enterprise-class packet sniffing in on-prem, public and private cloud environments, with rapid, centralized search and one-click access to full pcap data from leading security and performance solutions (including Microsoft, Palo Alto Networks, Fortinet, Cisco, Splunk, Elastic, and many others). Analyze network traffic using a single, unified console across all on-prem, private, or public cloud infrastructure for total hybrid cloud visibility. Capture every packet. See every threat. www.endace.com

About Artiza Networks

Artiza Networks is the leader in radio access network (RAN) and core network (CN) testing for 3G, 4G, and 5G. For over 30 years, Artiza has collaborated with the industry's top vendors and operators in testing the RAN and core network nodes of the world's most advanced cellular networks. With extensive engineering resources including PCB and FPGA/DSP development, award-winning customer support, and a sales force versed in mobile network technology, Artiza meets the full range of customer needs through innovative, in-house development of products and solutions.

Artiza Networks, Inc. (TSE 6778)
Established: 27 December 1990
www.artizanetworks.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20260708462599/en/

Contacts

For more information, contact:

Endace
Email: pr@endace.com
Phone:
Mark Evans, mobile +64-21-494 850 – New Zealand / APAC
Kimber Smith-Fidler, mobile +1 775 298 5260 – USA / North America
Leah Jones (The CommsCo), mobile +44 203 697 6680 – UK / EMEA

Artiza Networks
Network Product Business Operations
+81-42-529-3494
Contact: https://www.artizanetworks.com/contact.html#contactForm -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.artizanetw
orks.com%2Fcontact.html%23contactForm&esheet=54566111&newsitemid=20260708462599&
lan=en-US&anchor=https%3A%2F%2Fwww.artizanetworks.com%2Fcontact.html%23contactFo
rm&index=5&md5=8c4ea1dbb727fb3caf2797f5967b2ac2

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Cardiac Dimensions ® Announces Three Major Publications Demonstrating Long-Term Durability, Real-World Performance, and Broad Patient Benefit of the Carillon Mitral Contour System ®8.7.2026 16:05:00 CEST | Press Release

Cardiac Dimensions, a leader in transcatheter therapies for heart failure, today announced the publication of three major manuscripts that together form the most comprehensive evidence base ever assembled for transcatheter indirect mitral annuloplasty. These publications span a five-year multi-center commercial registry, the largest single-center experience across both preserved and reduced ejection fraction, and long-term survival results through ten years. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260707656796/en/ Carillon Mitral Contour System® The Carillon Mitral Contour System is the only commercially available indirect mitral annuloplasty device, designed to treat a broad and expanding population of patients living with functional mitral regurgitation. The newly published data further strengthen the clinical foundation for the therapy as Cardiac Dimensions advances toward regulatory submissions in the United State

First Randomized Controlled Trial Shows Promise of a Ketogenic Diet in Psychotic Disorders8.7.2026 15:00:00 CEST | Press Release

Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), and funded in part by the National Institute of Mental Health (NIMH), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders. The study, which enrolled participants with schizophrenia-spectrum or bipolar-1 disorders, demonstrated rapid metabolic improvements with a ketogenic diet compared to diet-as-usual during an initial one-month RCT open-label phase. Furthermore, those who continued with the optional four-month single-arm ketogenic diet extension saw meaningful gains across metabolic, psychiatric, and cognitive measures. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260618626815/en/ First Randomized Controlled Trial Shows Promise of a Ketogenic Diet in Psychotic Disorders Of the 58 participants enrolled,

Teamily AI Publicly Launches Human+AI Social Platform to Make Building and Growing a Company Easy for Every Team8.7.2026 15:00:00 CEST | Press Release

Teamily AI (https://Teamily.ai), together with its Agentic AI Infra platform TensorOpera AI (https://TensorOpera.ai), today announced the public launch of its Human+AI social platform, a product stack that has already served more than 5 million users around the world. Starting today in Palo Alto and rolling out simultaneously across dozens of countries, this first public launch opens the full stack to everyone with a single mission: to make building and growing a company easy for every person and every team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708584390/en/ "This is the moment we open our doors to the world," said co-founders Dr. Aiden Chaoyang He and Professor Salman Avestimehr. "We want every person and every team to be able to move from idea to product, from product to market, and from market to growth and investment, with an AI-native team by their side." At its core, Teamily AI enables humans and AI agents

Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform8.7.2026 14:30:00 CEST | Press Release

Leo Cancer Care, the medical technology company working to reinvent how patients are imaged and treated by designing systems around the body’s natural upright position, today announced the close of an oversubscribed $65 million Series D financing. The round was led by Silicon Valley’s Yu Galaxy and welcomes new investors including Eventide Asset Management, alongside continued support from the company’s existing investors. Leading cancer institutions are already adopting the upright approach. Stanford Medicine delivered the world’s first compact upright proton therapy treatment on 4 June 2026. Dana-Farber Cancer Institute and McLaren Health Care are among the institutions bringing the upright platform into their programmes — adoption that spans world-leading academic centers and smaller, regional community-based networks alike. The financing will scale manufacturing and accelerate commercial deployment, and continue clinical and product development across Leo Cancer Care’s integrated u

LUMI AI Factory Selects IQM to Deploy Advanced Quantum Computer, Accelerating Hybrid HPC and AI Development8.7.2026 14:00:00 CEST | Press Release

The LUMI AI Factory, led by CSC – IT Center for Science, has selected IQM Quantum Computers (Nasdaq: IQMX) to deliver IQM Halocene H4, an advanced quantum computer aimed at accelerating hybrid high-performance computing, artificial intelligence, and quantum computing capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708006791/en/ LUMI AI Factory selects IQM to deploy advanced quantum computer, accelerating hybrid HPC and AI development IQM Halocene H4 is the first and most advanced on-premises superconducting quantum computer of its kind, combining quantum error correction with NISQ qubits. The system will be delivered in 2027, followed by a series of upgrades delivered in multiple phases with an increasing number of logical qubits. The IQM Halocene H4 and the upgraded systems will enable LUMI consortium users, for the first time, to develop and implement Quantum Error Correction (QEC) concepts on a world-leadi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye